Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,642
datasets available to search
ShareScore release 0.9.0
Dataset results
2,642 results for “blindness”
Duloxetine for Chronic Depression: a Double-blind Study
ClinicalTrials.gov study NCT00360724. IPD Sharing: NO. Countries: 1. Publications: 4.
A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects
ClinicalTrials.gov study NCT00316524. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants
ClinicalTrials.gov study NCT02093923. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)
ClinicalTrials.gov study NCT01321554. IPD Sharing: Not stated. Countries: 23. Publications: 7.
A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy
ClinicalTrials.gov study NCT00683852. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.
ClinicalTrials.gov study NCT00159913. IPD Sharing: Not stated. Countries: 17. Publications: 5.
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
ClinicalTrials.gov study NCT02008773. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia.
ClinicalTrials.gov study NCT00333866. IPD Sharing: Not stated. Countries: 16. Publications: 5.
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
ClinicalTrials.gov study NCT00605826. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug
ClinicalTrials.gov study NCT00819091. IPD Sharing: Not stated. Countries: 7. Publications: 3.
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma
ClinicalTrials.gov study NCT01843374. IPD Sharing: YES. Countries: 19. Publications: 2.
Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia
ClinicalTrials.gov study NCT02409459. IPD Sharing: YES. Countries: 1. Publications: 1.
Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout
ClinicalTrials.gov study NCT01356498. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
ClinicalTrials.gov study NCT00140426. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's
ClinicalTrials.gov study NCT01862640. IPD Sharing: YES. Countries: 7. Publications: 7.
Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.
ClinicalTrials.gov study NCT03769194. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy
ClinicalTrials.gov study NCT00553475. IPD Sharing: Not stated. Countries: 1. Publications: 5.
A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients
ClinicalTrials.gov study NCT00449033. IPD Sharing: Not stated. Countries: 18. Publications: 1.
This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream
ClinicalTrials.gov study NCT03802344. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With
ClinicalTrials.gov study NCT01372410. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.